Review



mouse anti pd l1 antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Proteintech mouse anti pd l1 antibody
    Mouse Anti Pd L1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 627 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti pd l1 antibody/product/Proteintech
    Average 96 stars, based on 627 article reviews
    mouse anti pd l1 antibody - by Bioz Stars, 2026-02
    96/100 stars

    Images



    Similar Products

    anti mouse pd l1 b7 h1 antibody  (MedChemExpress)
    94
    MedChemExpress anti mouse pd l1 b7 h1 antibody
    Anti Mouse Pd L1 B7 H1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse pd l1 b7 h1 antibody/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    anti mouse pd l1 b7 h1 antibody - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    anti mouse pd l1 pe  (Thermo Fisher)
    94
    Thermo Fisher anti mouse pd l1 pe
    Anti Mouse Pd L1 Pe, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse pd l1 pe/product/Thermo Fisher
    Average 94 stars, based on 1 article reviews
    anti mouse pd l1 pe - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    p99145  (MedChemExpress)
    94
    MedChemExpress p99145
    P99145, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p99145/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    p99145 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    mouse anti pd l1 antibody  (Proteintech)
    96
    Proteintech mouse anti pd l1 antibody
    Mouse Anti Pd L1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti pd l1 antibody/product/Proteintech
    Average 96 stars, based on 1 article reviews
    mouse anti pd l1 antibody - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    anti human mouse pd l1  (Proteintech)
    96
    Proteintech anti human mouse pd l1
    Anti Human Mouse Pd L1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human mouse pd l1/product/Proteintech
    Average 96 stars, based on 1 article reviews
    anti human mouse pd l1 - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    anti mouse pd l1 antibody  (MedChemExpress)
    94
    MedChemExpress anti mouse pd l1 antibody
    In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), <t>anti-PD-L1</t> (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.
    Anti Mouse Pd L1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse pd l1 antibody/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    anti mouse pd l1 antibody - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    anti mouse pd l1  (MedChemExpress)
    94
    MedChemExpress anti mouse pd l1
    In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), <t>anti-PD-L1</t> (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.
    Anti Mouse Pd L1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse pd l1/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    anti mouse pd l1 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    antimouse pd l1 antibody  (MedChemExpress)
    94
    MedChemExpress antimouse pd l1 antibody
    In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), <t>anti-PD-L1</t> (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.
    Antimouse Pd L1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antimouse pd l1 antibody/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    antimouse pd l1 antibody - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    itacitinib  (MedChemExpress)
    94
    MedChemExpress itacitinib
    STAT1 inhibition assay. (A-B) Western blots and Annexin V/PI staining demonstrated that pharmacologic inhibition of STAT1 by <t>Itacitinib</t> abolished IFN-γ induced caspase-3 cleavage, and apoptosis in CT26.WT cells. Grayscale densitometry for all Western blots has been performed using ImageJ, normalized to β-actin (n = 3 independent experiments). Bars represent mean ± SD. Statistical comparison was performed using an unpaired two-tailed t-test.
    Itacitinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/itacitinib/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    itacitinib - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    rabbit anti mouse pdl1  (Proteintech)
    98
    Proteintech rabbit anti mouse pdl1
    STAT1 inhibition assay. (A-B) Western blots and Annexin V/PI staining demonstrated that pharmacologic inhibition of STAT1 by <t>Itacitinib</t> abolished IFN-γ induced caspase-3 cleavage, and apoptosis in CT26.WT cells. Grayscale densitometry for all Western blots has been performed using ImageJ, normalized to β-actin (n = 3 independent experiments). Bars represent mean ± SD. Statistical comparison was performed using an unpaired two-tailed t-test.
    Rabbit Anti Mouse Pdl1, supplied by Proteintech, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti mouse pdl1/product/Proteintech
    Average 98 stars, based on 1 article reviews
    rabbit anti mouse pdl1 - by Bioz Stars, 2026-02
    98/100 stars
    		  Buy from Supplier

    Image Search Results


    In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), anti-PD-L1 (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Combining Radiation and anti-PD-L1 Enhances the Antitumor Activity in Colorectal Cancer via IFN-γ-Dependent Activation of STAT1

    doi: 10.1177/15330338251406931

    Figure Lengend Snippet: In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), anti-PD-L1 (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.

    Article Snippet: Therapeutic agents: anti-mouse PD-L1 antibody (clone 10F.9G2), recombinant mouse IFN-γ and Itacitinib (both MedChemExpress).

    Techniques: In Vivo, Control, Irradiation

    STAT1 inhibition assay. (A-B) Western blots and Annexin V/PI staining demonstrated that pharmacologic inhibition of STAT1 by Itacitinib abolished IFN-γ induced caspase-3 cleavage, and apoptosis in CT26.WT cells. Grayscale densitometry for all Western blots has been performed using ImageJ, normalized to β-actin (n = 3 independent experiments). Bars represent mean ± SD. Statistical comparison was performed using an unpaired two-tailed t-test.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Combining Radiation and anti-PD-L1 Enhances the Antitumor Activity in Colorectal Cancer via IFN-γ-Dependent Activation of STAT1

    doi: 10.1177/15330338251406931

    Figure Lengend Snippet: STAT1 inhibition assay. (A-B) Western blots and Annexin V/PI staining demonstrated that pharmacologic inhibition of STAT1 by Itacitinib abolished IFN-γ induced caspase-3 cleavage, and apoptosis in CT26.WT cells. Grayscale densitometry for all Western blots has been performed using ImageJ, normalized to β-actin (n = 3 independent experiments). Bars represent mean ± SD. Statistical comparison was performed using an unpaired two-tailed t-test.

    Article Snippet: Therapeutic agents: anti-mouse PD-L1 antibody (clone 10F.9G2), recombinant mouse IFN-γ and Itacitinib (both MedChemExpress).

    Techniques: Inhibition, Western Blot, Staining, Comparison, Two Tailed Test